AstraZeneca notches win in ongoing 340B legal fight
The decision vacates a violation letter HHS sent to the drugmaker that argued it was illegally restricting discounts on drugs providers delivered through contract pharmacies.
The decision vacates a violation letter HHS sent to the drugmaker that argued it was illegally restricting discounts on drugs providers delivered through contract pharmacies.